Estado

n.d.

no disponible

Compartir

Datos de financiación (31/01/2020)

Contribuido
EUR 766.042,00
Objetivo máximo
EUR 500.000,00

Detalles

País
Finlandia FI
Sector
SaludBiotechnology
Fecha final
31/01/2020 (2398 días)

Descripción

“Askel offers a unique way to rebuild joint surfaces for pain-free movement. COPLA® is a medical device already on the 250M€ market for animal health with excellent clinical results. The next step is to enter into the 2.2B$ human market.”

Progreso de la financiación

Previa del proyecto